Endo Health Solutions Inc. (Nasdaq: ENDP) will acquire Paladin Labs for approximately $1.5 billion in cash and stock. Shares of the health care solutions provider leaped $12.61 to $56.27.
Endo Health To Buy Paladin Labs
November 05, 2013 at 06:01 AM EST
